Ledger.Open graph →
SEC Form D · filed October 25, 2024

Transition Bio, Inc

Offering
$21.3M
Sold
$13.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

George Martin · Cambrige, MAExec · DirectorRobert F. Levi · Cambridge, MAExec · DirectorTuomas Knowles · Cambridge, MADirectorKathy Yi · Cambridge, MADirectorRobert Weeks · Cambridge, MADirectorGeorge Martin · Cambrige, MAExec · DirectorAl Sandrock · Cambridge, MADirectorStephanie Torruella · Cambridge, MAExecSamuel Cohen · Cambridge, MADirectorPreet Makkar · Cambridge, MAExecPaxton Major · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗